Lee M. Jampol

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

John A. Wells, Adam R. Glassman, Allison R. Ayala et al. · Ophthalmology · 2016 · 1K citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +12

Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy

Jeffrey G. Gross, Adam R. Glassman, Lee M. Jampol et al. · JAMA · 2015 · 762 citations

Medicine, Ophthalmology, Pharmacotherapy +14

Development of Metastatic Disease After Enrollment in the COMS Trials for Treatment of Choroidal Melanoma

Marie Diener‐West, Sandra M. Reynolds, Donna J Agugliaro et al. · Archives of Ophthalmology · 2005 · 619 citations

Medicine, Oncology, Ophthalmology +17

Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment: 5-Year Randomized Trial Results

Michael J. Elman, Allison R. Ayala, Neil M. Bressler et al. · Ophthalmology · 2014 · 566 citations

Medicine, Ophthalmology, Surgery +13

Genetic variants near <i>TIMP3</i> and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration

Wei Chen, Dwight Stambolian, Albert O. Edwards et al. · Proceedings of the National Academy of Sciences · 2010 · 516 citations · Full text

Life Sciences, Genetics, Ophthalmology +13